| 1 |
30937691 | Correction to: A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL. | 2019 Aug |
2 |
| 2 |
31540423 | Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway. | 2019 Sep 18 |
1 |
| 3 |
29678549 | Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer. | 2018 Jul 28 |
1 |
| 4 |
27566568 | Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells. | 2016 Sep 20 |
1 |
| 5 |
25787766 | Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy. | 2015 Mar 18 |
2 |
| 6 |
25333266 | Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition. | 2014 Nov 30 |
2 |
| 7 |
23562878 | Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma. | 2013 Jul |
2 |
| 8 |
24058878 | ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells. | 2013 |
1 |
| 9 |
21773733 | A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL. | 2012 Aug |
1 |
| 10 |
22490358 | [The effect of cell killing by ABT-737 synergized with docetaxel in human prostate cancer PC-3 cells]. | 2012 Feb 1 |
1 |
| 11 |
21380817 | Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status. | 2011 Feb |
1 |
| 12 |
18594829 | Docetaxel and bortezomib downregulate Bcl-2 and sensitize PC-3-Bcl-2 expressing prostate cancer cells to irradiation. | 2008 Oct |
1 |
| 13 |
17722957 | Docetaxel: in gastric cancer. | 2007 |
1 |
| 14 |
15703816 | Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and docetaxel in a human prostate cancer PC-3 model. | 2005 Mar |
1 |
| 15 |
16052512 | PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism. | 2005 Oct 15 |
1 |
| 16 |
16080463 | Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel. | 2005 May-Jun |
7 |
| 17 |
11788897 | Cellular sensitivity determinants to docetaxel in human gastrointestinal cancers. | 2002 Feb |
1 |
| 18 |
11929841 | Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents. | 2002 Apr 1 |
1 |
| 19 |
11685722 | Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancer. | 2001 Aug |
1 |